3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
7
Motor Activity
4
Neoplasms
3
Colorectal Neoplasms
3
Smoking Cessation
2
Lung Neoplasms
2
Endometrial Neoplasms
2
Behavior
2
Smoking
1
Skin Cancer Prevention
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Patient Compliance
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Other Cancer
1
Obesity
1
Lymphedema
1
Colorectal Cancer Screening
1
Colonic Neoplasms
1
Body Weight Changes
1
Body Weight
1
Anxiety Disorders
1
Interventions
Fluorouracil
128
Leucovorin
120
Oxaliplatin
101
Irinotecan
89
Bevacizumab
55
Cetuximab
44
Capecitabine
40
Folfox protocol
29
Panitumumab
22
Colonoscopy
17
Chemotherapy, Adjuvant
16
Floxuridine
15
Early Intervention, Educational
15
Erlotinib Hydrochloride
13
Surveys and Questionnaires
11
IFL protocol
11
Counseling
11
Immunohistochemistry
10
Gemcitabine
10
Celecoxib
10
Psychiatric Rehabilitation
9
Methods
8
Magnetic Resonance Spectroscopy
8
Gene Expression Profiling
8
Exercise
8
Dexamethasone
8
sargramostim
7
Sorafenib
7
Radiotherapy
7
Nivolumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Colonic Neoplasms
×
Motivational Interviewing
×
Clear all
NCT03210129
2019-03-14
MIPAClux
Luxembourg Institute of Health
Phase NA
Completed
25 enrolled